| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $66.5M | — | +55.1% |
| SG&A Expense | $22.9M | — | +70.1% |
| Operating Income | -$89.4M | — | -58.7% |
| Pre-tax Income | -$75.8M | — | -62.1% |
| Income Tax | $190K | — | +93.9% |
| Net Income | -$76.0M | — | -62.2% |
| EPS (Basic) | -$0.35 | — | -29.6% |
| EPS (Diluted) | -$0.35 | — | -29.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $316.2M | -60.5% | +107.8% |
| Short-term Investments | $1.14B | +76.7% | +66.8% |
| Current Assets | $1.49B | -5.1% | +75.4% |
| Total Assets | $1.51B | -4.8% | +74.0% |
| Current Liabilities | $57.0M | -10.0% | +56.2% |
| Total Liabilities | $61.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.2M | — | +129.2% |
| Capital Expenditures | $1.2M | — | +276.4% |
| Investing Cash Flow | -$496.9M | — | -1560.2% |
| Financing Cash Flow | -$1.7M | — | -315.3% |
| Free Cash Flow | $14.1M | — | +126.7% |
| +45.6% |
| Stockholders' Equity | $1.45B | -4.6% | +75.5% |